<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">THIOTHIXENE HYDROCHLORIDE</span><br/>(thye-oh-thix'een)<br/><span class="topboxtradename">Navane<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">psychotherapeutic</span>; <span class="classification">phenothiazine antipsychotic</span><br/><b>Prototype: </b>Chlorpromazine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg, 2 mg, 5 mg, 10 mg, 20 mg capsules; 5 mg/mL solution</p>
<h1><a name="action">Actions</a></h1>
<p>Xanthene derivative chemically and pharmacologically similar to chlorprothixene and the piperazine phenothiazines. Mechanism
         of antipsychotic effects is unclear; thought to be related to blockade of postsynaptic dopamine receptors in the brain.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Possesses antipsychotic, sedative, adrenolytic, antiemetic, and weak anticholinergic activity.</p>
<h1><a name="uses">Uses</a></h1>
<p>Manifestations of psychotic disorders.</p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Antidepressant.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to thioxanthenes and phenothiazines; children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>History of convulsive disorders; alcohol withdrawal; glaucoma; prostatic hypertrophy; cardiovascular disease; patients who
         might be exposed to organophosphorus insecticides or to extreme heat; concomitant use of atropine or related drugs or ototoxic
         medications (especially ototoxic antibiotics); previously diagnosed breast cancer.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Psychotic Disorders</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 2 mg t.i.d., may increase up to 15 mg/d as needed or tolerated (max: 60 mg/d) <span class="rdroute">IM</span> 4 mg b.i.d. to q.i.d. (max: 30 mg/d)<br/><br/><span class="indicationtitle">Dementia Behavior</span><br/><span class="rdage">Geriatric:</span> <span class="rdroute">PO</span> 12 mg 12 times/d, may increase q47d (max: of 30 mg/d in divided doses)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Avoid contact between oral concentrate and skin or clothing to prevent contact dermatitis. If concentrate spills, wash skin
            promptly with water.
         </li>
<li>Give oral concentrate (contains 7% alcohol) diluted in a cupful of water, fruit juice, carbonated beverage, milk, or soup.</li>
<li>Empty capsule and give with water or mix with food; useful if patient unable or unwilling to swallow the capsule.</li>
</ul><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Give IM injection deep into upper outer quadrant of buttock. Aspirate carefully before injection. Rotate injection sites.</li>
<li>Do not permit access to more than one dose of medication if patient has suicidal tendency; supervise ingestion to prevent
            hoarding.
         </li>
<li>Store at 15°30° C (59°86° F) in light-resistant containers unless otherwise indicated.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness,</span> insomnia, dizziness, cerebral edema, convulsions, <span class="speceff-common">extrapyramidal symptoms (dose related),</span> paradoxical exaggeration of psychotic symptoms; <span class="speceff-life">sudden death, neuroleptic malignant syndrome</span>, tardive dyskinesia, depressed cough reflex. <span class="typehead">GI:</span> Xerostomia, constipation. <span class="typehead">CV:</span> Tachycardia, <span class="speceff-common">orthostatic hypotension</span> (especially with IM). <span class="typehead">Urogenital:</span> Impotence, gynecomastia, galactorrhea, amenorrhea. <span class="typehead">Skin:</span> Rash, contact dermatitis, photosensitivity. <span class="typehead">Special Senses:</span> Blurred vision, pigmentary retinopathy. <span class="typehead">Metabolic:</span> Decreased serum uric acid levels. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol,</b> <span class="classification">anxiolytics</span>, <span class="classification">sedative-hypnotics</span>, other <span class="classification">cns depressants</span> add to CNS depression; additive adverse effects with other <span class="classification">phenothiazines</span>; <span class="typehead">Herbal:</span> <b>Kava-kava</b> may increase risk and severity of dystonic reactions. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Slowly absorbed from GI tract. <span class="typehead">Onset:</span> Days to weeks PO; 16 h IM. <span class="typehead">Duration:</span> Up to 12 h. <span class="typehead">Distribution:</span> May remain in body for several weeks; crosses placenta. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in bile and feces. <span class="typehead">Half-Life:</span> 34 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor for therapeutic response. Although therapeutic response can be observed 16 h following IM injection, it may
            be days or several weeks before there is a response with oral drug.
         </li>
<li>Keep patient recumbent for at least 1 h following IM because of possibility of orthostatic hypotension. Check BP periodically.</li>
<li>Monitor BP for excessive hypotensive response when thiothixene is added to drug regimen of patient on hypertensive treatment
            until therapy is stabilized.
         </li>
<li>Monitor response when patient is changed from IM to PO forms (capsules, concentrate). Dosage adjustment may be necessary.</li>
<li>Monitor infants delivered from mothers who have received thiothixene. Hyperreflexia has been reported.</li>
<li>Lab tests: Periodic blood chemistry and liver function tests with prolonged therapy.</li>
<li>Report extrapyramidal effects (pseudoparkinsonism, akathisia, dystonia) to physician; dose adjustment or short-term therapy
            with an antiparkinsonism agent may provide relief.
         </li>
<li>Be alert to first symptoms of tardive dyskinesia (see Appendix F). Discontinue drug immediately and inform physician.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Make position changes slowly, particularly from lying down to upright because of danger of light-headedness; sit a few minutes
            before walking.
         </li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Avoid alcohol and other depressants during therapy.</li>
<li>Take drug as prescribed; do not alter dosing regimen or stop medication without consulting physician. Abrupt discontinuation
            can cause delirium.
         </li>
<li>Do not use any OTC drugs without approval of physician.</li>
<li> 							Note: Hyperhidrosis, while an uncomfortable adverse effect, does not indicate need to terminate therapy. 						</li>
<li>Avoid excessive exposure to sunlight to prevent a photosensitivity reaction. If sun exposure is expected, protect skin with
            sunscreen lotion (SPF 12 or above).
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
<li>Schedule periodic eye exams and report blurred vision to physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>